NWK Group’s CVS Health CVS Stock Holding History

NWK Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-146	Closed	-$9K	–	195
2020 Q2	$9K	Buy	+146	New	+$9.19K	0.01%	179

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NWK Group's CVS Position: Q3 2020 in Review

NWK Group sold out of CVS Health (CVS) in Q3 2020, closing a stake of 146 shares — an estimated $9K sold.

NWK Group first reported a position in CVS in Q2 2020 and held it in 1 quarter. The position peaked at $9K in Q2 2020. 1,815 funds tracked by Wall St. Rank hold CVS as of Q3 2020.

NWK Group reported no remaining CVS Health position as of Q3 2020 after selling out during the quarter.
NWK Group sold 146 CVS Health shares in Q3 2020, an estimated $9K.
NWK Group first reported a position in CVS Health in Q2 2020 and held it in 1 quarter.
NWK Group's CVS Health position peaked at $9K in Q2 2020.
1,815 funds tracked by Wall St. Rank held CVS Health as of Q3 2020.

Based on NWK Group's 13F filing for Q3 2020, filed 16 Nov 2020.